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COVID-19 is a global pandemic caused by the SARS-CoV-2 coronavirus. The T cell response is
a critical part of both individual and herd immunity to SARS-CoV-2 and the efficacy of developed
vaccines. However neither the dynamics and cross-reactivity of the SARS-CoV-2-specific T cell
response nor the diversity of resulting immune memory are well understood. In this study we use
longitudinal high-throughput T cell receptor sequencing to track changes in the T cell repertoire fol-
lowing two mild cases of COVID-19 infection. In both donors we identified SARS-CoV-2-responding
CD4+ and CD8+ T cell clones. We describe characteristic motifs in TCR sequences of COVID-
19-reactive clones, suggesting the existence of immunodominant epitopes. We show that in both
donors the majority of infection-reactive clonotypes acquire memory phenotypes. Certain CD4+
clones were detected in the memory fraction at the pre-infection timepoint, suggesting participation
of pre-existing cross-reactive memory T cells in the immune response to SARS-CoV-2.
INTRODUCTION
COVID-19 is a global pandemic caused by the novel
SARS-CoV-2 betacoronavirus [1]. T cells are crucial for
clearing respiratory viral infections and providing long-
term immune memory [2, 3]. Two major subsets of T
cells participate in the immune response to viral infec-
tion in different ways: activated CD8+ T cells directly
kill infected cells, while subpopulations of CD4+ T cells
produce signaling molecules that regulate myeloid cell
behaviour, drive and support CD8 response and the for-
mation of long-term CD8 memory, and participate in the
selection and affinity maturation of antigen specific B-
cells, ultimately leading to the generation of neutralizing
antibodies. In SARS-1 survivors, antigen-specific mem-
ory T cells were detected up to 11 years after the ini-
tial infection, when viral-specific antibodies were unde-
tectable [4, 5]. The T cell response was shown to be
critical for protection in SARS-1-infected mice [6]. Pa-
tients with X-linked agammaglobulinemia, a genetic dis-
order associated with lack of B cells, have been reported
to recover from symptomatic COVID-19 [7, 8], suggesting
that in some cases T cells are sufficient for viral clearance.
Theravajan et al. showed that activated CD8+HLA-
DR+CD38+ T cells in a mild case of COVID-19 signif-
icantly expand following symptom onset, reaching their
peak frequency of 12% of CD8+ T cells on day 9 af-
ter symptom onset, and contract thereafter [9]. Given
the average time of 5 days from infection to the onset
of symptoms [10], the dynamics and magnitude of T cell
response to SARS-CoV-2 is similar to that observed af-
ter immunization with live vaccines [11]. The exact im-
munodominant CD8+ and CD4+ SARS-CoV-2 epitopes
are yet unknown. However, SARS-CoV-2-specific T cells
were detected in COVID-19 survivors by activation fol-
lowing stimulation with SARS-CoV-2 proteins [12], or
by viral protein-derived peptide pools [13, 14]. Some of
the T cells activated by peptide stimulation were shown
to have a memory phenotype [13], and some potentially
cross-reactive CD4+ T cells were found in healthy donors
[14, 15].
T cells recognise short pathogen-derived peptides pre-
sented on the cell surface of the Major Histocompatibil-
ity Complex (MHC) using hypervariable T cell receptors
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2(TCR). TCR repertoire sequencing allows for the quanti-
tative tracking of T cell clones in time, as they go through
the expansion and contraction phases of the response. It
was previously shown that quantitative longitudinal TCR
sequencing is able to identify antigen-specific expand-
ing and contracting T cells in response to yellow fever
vaccination with high sensitivity and specificity [16–18].
Not only clonal expansion but also significant contraction
from the peak of the response are distinctive traits of T
cell clones specific to the virus [17].
In this study we use longitudinal TCRalpha and TCR-
beta repertoire sequencing to quantitatively track T cell
clones that significantly expand and contract after a mild
COVID-19, and determine their phenotype. We reveal
the dynamics and the phenotype of the memory cells
formed after infection, identify pre-existing T cell mem-
ory clones participating in the response, and describe
public TCR sequence motifs of SARS-nCoV-2-reactive
clones, suggesting a response to immunodominant epi-
topes.
RESULTS
On March 14th (day 0) donor W, 27 year old fe-
male and donor M, 28 year old male, returned to Russia
from the Rhoˆne-Alpes region of France, one of the cen-
ters of the COVID-19 outbreak in France at the time.
Upon arrival, according to local regulations, they were
put into strict self-quarantine for 14 days. On day
3 of self-isolation both developed low grade fever, fa-
tigue and myalgia, which lasted 4 days and was fol-
lowed by a temporary loss of smell for donor M. On days
15, 30, 37 and 45 we collected peripheral blood sam-
ples from both donors. The presence of SARS-CoV-2
specific antibodies in the plasma was measured at all
timepoints using SARS-CoV-2 S-RBD domain specific
ELISA (Fig. S1). From each blood sample we isolated
PBMCs (peripheral blood mononuclear cells, in two bi-
ological replicates), CD4+, and CD8+ T cells. Addi-
tionally, on days 30 and 45 we isolated four T cell mem-
ory subpopulations (Fig. S2): Effector Memory (EM:
CCR7-CD45RA-), Effector Memory with CD45RA re-
expression (EMRA: CCR7-CD45RA+), Central Mem-
ory (CM: CCR7+CD45RA-), and Stem Cell-like Memory
(SCM: CCR7+CD45RA+CD95+). From all samples we
isolated RNA and performed TCRalpha and TCRbeta
repertoire sequencing as previously described [19]. For
both donors, TCRalpha and TCRbeta repertoires were
obtained for other projects one and two years prior to in-
fection. Additionally, TCR repertoires of multiple sam-
ples for donor M – including sorted memory subpopula-
tions – are available from a published longitudinal TCR
sequencing study after yellow fever vaccination (donor
M1 samples in [16]).
From previously described activated T cell dynamics
for SARS-CoV-2 [9], and immunization with live vac-
cines [11], the peak of the T cell expansion is expected
around day 15 post-infection, and responding T cells sig-
nificantly contract by day 45. However, Weiskopf et
al. [13] reports an increase of SARS-CoV-2-reactive T
cells at later timepoints, peaking in some donors after
30 days following symptom onset. To identify groups
of T cell clones with similar dynamics in an unbiased
way, we used Principal Component Analysis (PCA) in
the space of T cell clonal trajectories (Fig. 1b and c). In
both donors, and in both TCRalpha and TCRbeta reper-
toires, we identified three clusters of clones with distinct
dynamics. The first cluster (Fig. 1bc, purple) corre-
sponded to abundant TCR clonotypes which had con-
stant concentrations across timepoints, the second clus-
ter (Fig. 1bc, green) showed contraction dynamics from
day 15 to day 45, and the third cluster (Fig. 1bc, yel-
low), showed an unexpected clonal expansion from day
15 with a peak on day 37 followed by contraction. The
clustering and dynamics are similar in both donors and
are reproduced in TCRbeta (Fig. 1bc) and TCRalpha
(Fig. S3) repertoires. We next used edgeR, a software for
differential gene expression analysis [20], to specifically
detect changes in clonotype concentration between pairs
of timepoints in a statistically reliable way. EdgeR uses
biological replicate samples collected at each timepoint
to train a negative-binomial noise model. We identified
374 TCRalpha and 373 TCRbeta clonotypes in donor W,
and 797 TCRalpha and 672 TCRbeta in donor M signifi-
cantly contracted from day 15 to day 45 (largely overlap-
ping with cluster 2 of clonal trajectories). 438 TCRal-
pha and 533 TCRbeta for donor W, and 531 TCRalpha
and 599 TCRbeta clonotypes for donor M were signif-
icantly expanded from day 15 to 37 (corresponding to
cluster 3 of clonal trajectories). Reproducing the analysis
using NoiseET, a Bayesian differential expansion model
[21], yielded similar results (see Fig. S4), suggesting
that our results are robust to the choice of statistical
model and parameter inference procedure. Note that,
to identify putatively SARS-CoV-2 reactive clones, we
only used post-infection timepoints, so that our analysis
can be reproduced in other patients and studies where
pre-infection timepoints are unavailable. However, track-
ing the identified responding clones back to pre-infection
timepoints reveals strong clonal expansions from pre- to
post-infection (Fig. 1de, Fig. S3cd). For brevity, we
further refer to clonotypes significantly contracted from
day 15 to 45 as contracting clones and clonotypes sig-
nificantly expanding from day 15 to 37 as expanding
clones. For each contracting and expanding clone we
determined their CD4/CD8 phenotype using separately
sequenced repertoires of CD4+ and CD8+ subpopula-
tions (see Methods). Both CD4+ and CD8+ subsets
participated actively in the response (Fig. 1de). Inter-
estingly, clonotypes expanding after day 15 were signifi-
cantly biased towards the CD4+ phenotype, while con-
tracting clones had balanced CD4/CD8 phenotype frac-
tions in both donors (Fisher exact test, p < 0.0001 for
both donors).
On days 30 and 45 we identified both contracting (Fig.
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FIG. 1. Longitudinal tracking of T cell clones after mild COVID-19. a, Study design. Peripheral blood of two
donors was sampled longitudinally on days 15, 30, 37, 45 after arrival in Russia. At each timepoint, we evaluated SARS-CoV-
2-specific antibodies using ELISA (Fig. S1) and isolated PBMCs in two biological replicates. Additionally, CD4+ and CD8+
cells were isolated from a separate portion of blood, and EM, CM, EMRA, SCM memory subpopulations were FACS sorted
on days 30 and 45. For each sample we sequenced TCRalpha and TCRbeta repertoires. For both donors pre-infection PBMC
repertoires were sampled in 2018 and 2019 for other projects. b,c, PCA of clonal temporal trajectories identifies three
groups of clones with distinctive behaviours. Left: first two principal components of the 1000 most abundant TCRbeta
clonotype normalized frequencies in PBMC at post-infection timepoints. Right: mean ± 2.96 SE of the normalized trajectory
of TCR clones in each cluster. Contracting (d) and expanding (e) clones include both CD4+ and CD8+ T cells,
and are less abundant in pre-infection repertoires. T cell clones significantly contracted from day 15 to day 45 (d) and
significantly expanded from day 15 to day 37 (e) were identified using edgeR in both donors. The fraction of contracting (d)
and expanding (e) TCRbeta clonotypes in the total repertoire (corresponding to the fraction of responding cells of all T cells)
is plotted in log-scale for all reactive clones (left), reactive clones with the CD4 (middle) and CD8 (right) phenotypes. Similar
dynamics were observed in TCRalpha repertoires (Fig. S3), and for significantly expanded/contracted clones identified with
the NoisET Bayesian differential expansion statistical model (Fig. S4).
2a,b) and expanding (SI Fig. 5a-c) T cell clones in the
memory subpopulations of peripheral blood. Both CD4+
and CD8+ responding clones were found in the CM and
EM subsets, however CD4+ were more biased towards
CM, and CD8+ clones much more represented in the
EMRA subset. A small number of both CD4+ and CD8+
responding clonotypes were also identified in the SCM
subpopulation, which was previously shown to be a long-
lived T cell memory subset [22]. Intriguingly, a number
of responding CD4+ clones, but very few CD8+ clones,
were also represented in the repertoires of both donors 1
and 2 years before the infection. Pre-existing clones were
expanded after infection, and contracted afterwards for
both donors (SI Fig. 6). For donor M, for whom we had
previously sequenced memory subpopulations before the
infection [16], we were able to identify pre-existing SARS-
CoV-2-reactive CD4+ clones in the CM subpopulation 1
year before the infection. Interestingly, on day 30 after
infection the majority of pre-infection CM clones were
detected in the EM subpopulation, suggesting recent T
cell activation and a switch of the phenotype from mem-
ory to effector. These clones might represent memory T
cells cross-reactive for other infections, e.g. other human
coronaviruses. The search for responding clones TCR-
beta amino acid sequences in VDJdb [23] – a database of
TCRs with known specificity – resulted in essentially no
overlap: a total of 3 matches all corresponded to the EBV
(Epstein-Barr virus) epitope presented by the HLA-A*03
MHC allele, which is absent in both donors (SI Table 1).
At the time of the analysis there were no SARS-1, SARS-
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FIG. 2. Memory phenotypes and TCR sequence motifs of responding clonotypes contracting after day 15.
a, A large fraction of contracting clonotypes is identified in T cell memory subsets after infection. Fraction
of contracting CD4+ and CD8+ TCRbeta clonotypes present in 1-year and 2-year pre-infection PBMC and in at least one
of memory subpopulation sampled on day 30 and day 37 post infection. b, Responding clones are found in different
memory subsets. For both W (left) and M (right) donors, CD4+ clonotypes were more frequently found in the Central
Memory (CM) subset than CD8+ T cells, and both CD4+ and CD8+ contracting clonotypes were present in the Effector
Memory (EM) compartment. c, For donor M (right), CD4+ (but few CD8+) contracting clonotypes are also identified in
memory subsets 1 year before the infection, with a bias towards the CM subpopulation. d, Analysis of TCR amino
acid sequences of contracting clones reveal distinctive motifs. Each vertex in the similarity network corresponds
to a contracting clonotype. An edge indicates 2 or less amino acid mismatches in the CDR3 region (and identical V and J
segments). Networks are plotted separately for CD4alpha (d), CD4beta (e), CD8alpha (f) and CD8beta (g) contracting
clonotypes. Clonotypes without neighbours are not shown. Sequence logos corresponding to the largest clusters are shown
under the corresponding network plots.
CoV-2 or any other coronavirus-specific TCR sequences
in VDJdb, so the absence of matches suggests that con-
tracting and expanding clones are unlikely to be specific
for immunodominant epitopes of common pathogens cov-
ered in VDJdb.
It was previously shown that TCRs recognising the
same antigens frequently have highly similar TCR se-
quences [24, 25]. To identify motifs in TCR amino
acid sequences, we plotted similarity networks for sig-
nificantly contracted (Fig. 2d-g) and expanded (Fig.
5S5d-g) clonotypes. In both donors we found clusters
of highly similar clones in both CD4+ and CD8+ sub-
sets for expanding and contracting clonotypes. Clus-
ters were largely donor-specific, as expected, since our
donors have dissimilar HLA alleles (SI Table 1) and thus
each is likely to present a non-overlapping set of T cell
antigens. The largest cluster, described by the motif
TRAV35-CAGXNYGGSQGNLIF-TRAJ42, was identi-
fied in donor M’s CD4+ contracting alpha chains. Clones
from this cluster constituted 15.3% of all of donor M’s
CD4+ responding cells on day 15, suggesting a response
to an immunodominant CD4+ epitope in the SARS-
CoV-2 proteome. The high similarity of the TCR se-
quences of responding clones in this cluster allowed us to
independently identify motifs from donor M’s CD4 alpha
contracting clones using the ALICE algorithm [26] (Fig.
S8). While the time dependent methods (Fig. 1) identify
abundant clones, the ALICE approach is complementary
to both edgeR and NoisET as it identifies clusters of T
cells with similar sequences independently of their indi-
vidual abundances. Finding highly similar responding
TCR sequences in both donors, despite their different
HLA types, suggests that some of the identified respond-
ing clones could be public, and are likely to be found in
other SARS-CoV-2 infected individuals. Using a mecha-
nistic model of TCR recombination [27, 28] we predicted
the probability of occurrence of the reactive clones (see
Methods). For TCRbeta we also looked for the identi-
fied contracting and expanding clones in a large public
dataset of TCRbeta repertoires from [29]. The TCRbeta
occurrence probability correlated well with the frequency
of contracting and expanding clones in this public dataset
(Fig. S7), suggesting that at least a fraction of the SARS-
CoV-2 responding clones are public and are likely to be
shared between patients.
DISCUSSION
Using longitudinal repertoire sequencing, we identified
a group of CD4+ and CD8+ T clones that contract af-
ter recovery from a coronavirus infection. Our response
timelines agree with T cell dynamics reported by Ther-
avajan et al. [9] for mild COVID-19, as well as with
dynamics of T cell response to live vaccines [11]. Surpris-
ingly, in both donors we also identified a group of predom-
inantly CD4+ clonotypes which expanded from day 15 to
day 37 after the infection. One possible explanation for
this second wave of expansion is the priming of CD4+ T
cells by antigen-specific B-cells, but there might be other
mechanisms such as the migration of SARS-CoV-2 spe-
cific T cells from lymphoid organs. It is also possible that
later expanding T cells are triggered by another infection,
simultaneously and asymptomatically occurring in both
donors around day 30. The major limitation of our study
is that we do not know the specificity of contracted and
expanded clones observed after infection. However, accu-
mulation of TCR sequences from SARS-CoV-2-specific T
cells will allow us to connect the TCR motifs we described
to particular epitopes of the virus and estimate their rel-
ative contribution to the immune response. Databases of
SARS-CoV-2-associated TCR sequences combined with
sequencing of patients’ TCR repertoires will allow for the
tracking of the adaptive immune response in the early
stages of the disease, and possibly identify features cor-
relating with clinical outcomes. We showed that a large
fraction of putatively SARS-CoV-2 reactive T cell clones
are later found in memory subpopulations, and a subset
of CD4+ clones were identified in pre-infection central
memory subsets. The presence of SARS-CoV-2 cross-
reactive CD4 T cells in healthy individuals was recently
demonstrated [14, 15]. Our data further suggests that
cross-reactive CD4+ T cells can participate in the re-
sponse in vivo. It is interesting to ask if the presence
of cross-reactive T cells before infection is linked to the
mildness of the disease. Larger studies with cohorts of
severe and mild cases with pre-infection timepoints are
needed to address this question.
METHODS
Donors and blood samples
Peripheral blood samples from two healthy volunteers,
donor W (female, 27 years old) and donor M (male, 28
years old) were collected with written informed consent in
a certified diagnostics laboratory. Both donors gave writ-
ten informed consent to participate in the study under
the declaration of Helsinki. HLA alleles of both donors
(SI Table 1) were determined by an in-house cDNA high-
throughput sequencing method.
SARS-CoV-2 S-RBD domain specific ELISA
An ELISA assay kit developed by the National Re-
search Centre for Hematology was used for detection of
anti-S-RBD IgG according to the manufacturer’s proto-
col. The relative IgG level was calculated by dividing the
OD (optical density) values by the mean OD value of the
cut-off positive control serum supplied with the Kit. OD
values of 2 samples (d37 and d45) for donor M exceeded
the limit of linearity for the Kit. In order to properly
compare the relative IgG levels between d30, d37 and
d45, these samples were diluted 1:400 instead of 1:100,
the ratios d37:d30 and d45:d30 were calculated and used
to calculate the relative IgG level of d37 and d45.
Isolation of PBMCs and T cell subpopulations
PBMCs were isolated with the Ficoll-Paque density
gradient centrifugation protocol. CD4+ and CD8+ T
cells were isolated from PBMCs with Dynabeads CD4+
6and CD8+ positive selection kits respectively. For iso-
lation of EM, EMRA, CM and SCM memory subpop-
ulations we stained PBMCs with the following anti-
body mix: anti-CD3-FITC (UCHT1, eBioscience), anti-
CD45RA-eFluor450 (HI100, eBioscience), anti-CCR7-
APC (3D12, eBioscience), anti-CD95-PE (DX2, eBio-
science). Cell sorting was performed on FACS Aria III,
all four isolated subpopulations were lysed with Trizol
reagent immediately after sorting.
TCR library preparation and sequencing
TCRalpha and TCRbeta cDNA libraries preparation
was performed as previously described in [19]. RNA
was isolated from each sample using Trizol reagent ac-
cording to the manufacturer’s instructions. A universal
primer binding site, sample barcode and unique molec-
ular identifier (UMI) sequences were introduced using
the 5’RACE technology with TCRalpha and TCRbeta
constant segment specific primers for cDNA synthesis.
cDNA libraries were amplified in two PCR steps, with
introduction of the second sample barcode and Illumina
TruSeq adapter sequences at the second PCR step. Li-
braries were sequenced using the Illumina NovaSeq plat-
form (2x150bp read length).
TCR repertoire data analysis
Raw data preprocessing. Raw sequencing data was
demultiplexed and UMI guided consensuses were built us-
ing migec v.1.2.7 [30]. Resulting UMI consensuses were
aligned to V and J genomic templates of the TRA and
TRB locus and assembled into clonotypes with mixcr
v.2.1.11 [31]. See SI Table 2 for the number of cells,
UMIs and unique clonotypes for each sample.
Identification of clonotypes with active dynam-
ics. Principal component analysis (PCA) of clonal tra-
jectories was performed as described before [16]. First
we selected clones which were present among the top
1000 abundant in any of post-infection PBMC reper-
toires. Next, for each clone we calculated its frequency at
each post-infection timepoint and divided this frequency
by the maximum frequency of this clone for normaliza-
tion. Then we performed PCA on the resulting normal-
ized clonal trajectory matrix and identified three clusters
of trajectories with hierarchical clustering with complete
linkage, using Euclidean distances between trajectories.
We identify statistically significant contractions and ex-
pansions with edgeR as previously described [17], using
FDR adjusted p < 0.01 and log2 fold change threshold
of 1. NoisET implements the Bayesian detection method
described in [21]. Briefly, a two-step noise model account-
ing for cell sampling and expression noise is inferred from
replicates, and a second model of expansion is learned
from the two timepoints to be compared. The procedure
outputs the posterior probability of expansion or contrac-
tion, and the median estimated log2 fold change, whose
thresholds are set to 0.05 and 1 respectively.
TCR generative probability estimation. Models
of V(D)J-recombination for the TCRalpha and TCRbeta
loci were inferred for each individual using IGoR [32].
Selection models were then inferred and evaluated using
SONIA [28] to estimate TCR occurrence probabilities.
Data availability
Raw sequencing data are deposited to the Short Read
Archive (SRA) accession: PRJNA633317. Processed
TCRalpha and TCRbeta repertoire datasets, resulting
repertoires of SARS-CoV-2-reactive clones, and raw data
preprocessing instructions can be accessed from: https:
//github.com/pogorely/Minervina_COVID.
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FIG. S1. Both donors developed anti-SARS-CoV-2 IgG response by day 30 post infection. The relative level of
SARS-CoV-2 S-RBD domain specific IgG (y-axis) is plotted against time. Solid black line shows the threshold for positive
testing.
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FIG. S2. Memory subpopulation gating strategy. Three populations of memory T cells: EM, CM and EMRA are
defined by CCR7 and CD45RA markers, SCM are distinguished from naive CCR7+ CD45RA+ T cells by CD95 expression.
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FIG. S3. Longitudinal tracking of T cell clones after mild COVID-19 with TCRalpha repertoire sequencing.
a,b, PCA of clonal temporal trajectories identifies three groups of clones with distinctive behaviours. Left:
first two principal components of 1000 most abundant TCRalpha clonotype normalized frequencies at post-infection PBMC
timepoints. Right: mean +- 2.96 SE of the normalized trajectory of TCR clones in each cluster. c,d Contracting and
expanding clones include both CD4+ and CD8+ T cells and are less abundant in pre-infection repertoires.
T cell clones significantly contracted from day 15 to day 45 (c) and significantly expanded from day 15 to day 37 (d) were
identified using edgeR in both donors. The fraction of contracting (c) and expanding (d) TCRalpha clonotypes in the total
repertoire (corresponding to the fraction of responding cells of all T cells) is plotted in log-scale for all reactive clones (left),
reactive clones with the CD4 (middle) and the CD8 phenotype (right).
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FIG. S4. Comparison of clonal expansion detection procedures. The fraction (plotted in the log-scale) of contracting
(a) and expanding (d) TCRbeta clonotypes in the total repertoire was estimated using subsets of expanded and contracted
clones called by edgeR (green) and NoisET (purple) models. Overlaps for contracted clones (b,c) and expanded clones (e,f)
identified by both models are shown on the right.
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FIG. S5. Memory phenotypes and TCR sequence motifs of responding clonotypes expanding from day 15 to
day 37. a, A large fraction of expanding clonotypes is identified in T cell memory subsets after infection. A
small fraction of expanding CD4+ and CD8+ TCRbeta clonotypes present in 1-year and 2-year pre-infection PBMC and in
at least one of memory subpopulation sampled on day 30 and day 37 post infection. b, Responding clones are found
in different memory subsets. For both W (left) and M (right) donors, CD4+ clonotypes were more frequently found in
the Central Memory (CM) subset than CD8+ T cells, and both CD4+ and CD8+ expanding clonotypes were present in the
Effector Memory (EM) compartment. c, For donor M (right), CD4+ (but few CD8) expanding clonotypes are also identified
in memory subsets 1 year before the infection, with a bias towards the CM subpopulation. d, Analysis of TCR amino
acid sequences of expanding clones revealed distinctive motifs. Each vertex in the similarity network corresponds to
a expanding clonotype. An edge indicates 2 or less amino acid mismatches in the CDR3 region (same V and J segments are
required for connected vertices). Networks are plotted separately for CD4alpha (d), CD4beta (e), CD8alpha (f) and CD8beta
(g) contracting clonotypes. Clonotypes without neighbours are not shown. Sequence logos corresponding to the largest clusters
are shown under corresponding network plots.
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FIG. S6. Dynamics of pre-existing SARS-CoV-2 responding clones. The fraction of pre-existing (identified in -
1 yr and/or -2 yr timepoint pre-infection) contracting (a) and expanding (b) TCRbeta clonotypes in the total repertoire
(corresponding to the fraction of responding cells of all T cells) is plotted in log-scale for all reactive clones (left), reactive
clones with the CD4 (middle) and the CD8 phenotype (right).
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FIG. S7. TCR occcurence probability predicts public responding clonotypes. a Probability of TCR generation
and selection (Ppost) of TCRbeta clones with active dynamics (both contracted and expanded from both donors) is strongly
correlated with the occurrence of these clones in the large public database of TCRbeta repertoires from Emerson et al. [29].
(b)Distribution for TCR occurency probability of SARS-CoV-2 responding TCRbeta clonotypes. Dashed line shows TCR oc-
currence probability distribution for all clones in total repertoire. Some identified clones are public and have large recombination
probabilities, and thus are expected to be shared with additional SARS-CoV-2 patients.
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FIG. S8. ALICE algorithm output for TCRalpha PBMC repertoire of donor M on day 15. Similarity network
shows ALICE hits (clones in repertoire with more neighbours than expected by chance), which differ by 2 mismatches or less in
TCRalpha amino acid sequence. Darker colors indicate larger frequency of clone in the repertoire, vertex size indicates degree.
The majority (54%, 99/183) of hits identified by the algorithm correspond to a single large TRAV35/TRAJ42 cluster of CD4+
contracting clones also seen on Fig. 1d.
